Hedera helix as a medicinal plant

• Autorzy: Lutsenko Y , Bylka W. , Matlawska I. , Darmohray R.

Warianty tytułu

PL

Hedera helix jako roslina lecznicza

• Języki publikacji: EN

Abstrakty

EN

Hederae folium is used for the treatment of respiratory tract diseases with intense mucous formation, respiratory tract infections and in irritating cough which stems from common cold. According to clinical experiments, the effectiveness and tolerance of ivy preparations is good. The major compounds responsible for the biological activity are triterpene saponins. Ivy leave extracts exhibit spasmolytic/antispasmodic, anti-inflammatory, antimicrobial, analgesic, anthelmintic, antitrypanosomial, antileishmanial, antitumor, antimutagenic, moluscocidal, antioxidant and antithrombin activities.

PL

Hederae folium stosuje się w leczeniu schorzeń dróg oddechowych z nadmiernym wydzielaniem śluzu, w infekcjach dróg oddechowych oraz w męczącym kaszlu. Badania kliniczne potwierdzają skuteczność i dobrą tolerancję preparatów zawierających wyciąg z liści bluszczu. Głównymi składnikami odpowiedzialnymi za aktywność biologiczną są saponiny triterpenowe. Wyciągi z liści bluszczu wykazują różne typy aktywności: spazmolityczną/przeciwskurczową, przeciwzapalną, przeciwdrobnoustrojową, przeciwbólową, przeciwrobaczą, przeciwnowotworową, antymutagenną, antyoksydacyjną, przeciwzakrzepową oraz przeciwpierwotniakową i przeciwmięczakową.

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2010
• Tom: 56
• Numer: 1
• Opis fizyczny: p.83-96,ref.

Twórcy

autor

Lutsenko Y

• Danylo Halytsky Lviv National Medical University, Pekarska 69, 79-010 Lviv, Ukraine

autor

Bylka W.

autor

Matlawska I.

autor

Darmohray R.

Bibliografia

• 1. E/S/C/O/P. Monographs. 2nd еd., Stuttgart 2003:241-7.
• 2. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. Medical Economics Company, Montvale2000:284-5.
• 3. Hänsel R, Keller K, Rimpler H, Schneider G. Drogen E-O. Berlin: Springer-Verlag 1993:399-404.
• 4. Blumenthal M. Herbal Medicine Expanded Commission E. Monographs. 1st ed. Austin 2000: 215-218.
• 5. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim) 1995; 328(10): 720-724.
• 6. United States Patent 20070031516 A1 USA A61K36/24; A61K31/7048; A61K31/522; A61K31/205; A61K31/13; A61K36/899. Composition for the prevention and treatment of cellulitis / A.Garcia, M.Jose,
• P.Cebrian / ES /.- Application Number: 10/551010.-Filing Date: 03/18/2004; Publication Date: 02/08/2007.
• 7. Wichtl M. Herbal Drugs and Phytopharmaceuticals. A Handbook for Practice on a Scientific Basis. 3rd ed. Stuttgart 2004:274-7.
• 8. Grishkovec VI, Kondratenko AJe, Tolkachova NV, Shashkov AS. Triterpene glycosides of Hedera helix I. Structure of glycosides L-1, L-2a, L-2b, L-3, L-4a, L-4b, L-6a, L-6b, L-6c, L-7a and L-7b from Hedera helix leaves. Chimija prirodnyh sojedinenij 1994; 6:742-6.
• 9. Crespin F, Elias R, Morice C, Ollivier E, Balansard G, Faure R. Identification of 3-O-β-D-glucopyranosylhederagenin from the leaves of Hedera helix. Fitoterapia LXVI 1995; (5):477.
• 10. Trute A, Nahrstedt A. Identification and quantitative analysis of phenolic compounds from the dry extract of Hedera helix. Planta Med 1997; 63(2):177-9.
• 11. Gafner F, Reynolds GW, Rodriguez E. The diacetylene 11, 12-dehydrofalcarinol from Hedera helix. Phytochemistry 1989; 28(4):1256-7.
• 12. Machran GH, Hilal SH, el-Alfy TS. The isolation and characterisation of emetine alkaloid from Hedera helix. Planta Med 1975; 27(2):127-32.
• 13. Hodisan T, Culea M, Cimpoiu C, Cot A. Separation, identification and quantitative determination of free amino acids from plant extractes. J Pharmac Biomed Anal 1998; 18(3):319-23.
• 14. Bedir E, Kirmizipekmez H, Sticher O, Calis I. Triterpene saponins from the fruits of Hedera helix. Phytochemistry 2000; 53(8):905-9.
• 15. Grosbois M. Biosynthèse des acides gras au cours du développement du fruit et de la graine du lierre. Phytochemistry 1971; 10(6):1261-73.
• 16. Christensen LP, Lam J, Thomasen T. Polyacetylenes from the fruits of Hedera helix. Phytochemistry 1991; 30(12):4151-2.
• 17. Gleeson PA, Jermyn MA. Alteration in the composition of β-lectins caused by chemical and enzymic attack. Austral J Plant Physiol 1979; 6(1):25-38.
• 18. Trute A, Gross J, Mutschler E, Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med 1997; 63(2):125-9.
• 19. European Pharmacopoeia. 7th ed. Monograph. 01/2008:2148.
• 20. Häberlein H. Hedera helix – mechanizm działania potwierdzony badaniami biologicznymi i biofizycznymi na modelu komórkowym. Przewodnik Lekarza 2009; 1:255-6.
• 21. Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, Runkel F, Häberlein H. Alpha-hederin, but not deracoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta 2-adrenergic receptors. Biochemistry 2009; 48(15):3477-82.
• 22. Hegener O, Prenner L, Runkel F, Baader SL, Kappler J, Häberlein H. Dynamics of beta 2-adrenergic receptor-ligand complexes on living cells. Biochemistry 2004; 43(20): 6190-9.
• 23. Süleyman H, Mshvildadze V, Gepdiremen A, Elias R. Acute and chronic antiinflammatory profile of the ivy plant, Hedera helix, in rats. Phytomedicine 2003; 10(5):370-
• 24. Gepdiremen A, Mshvildadze V, Süleyman H, Elias R. Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine 2005; 12 (6-7): 440-444.
• 25. Cioaca C, Margineanu C, Cucu V. The saponins of Hedera helix with antibacterial activity. Pharmazie 1978; 33(9):609-10.
• 26. Ieven M, Vanden Berghe DA, Mertens F, Vlietinck A, Lammens E. Screening of higher plants for biological activities. I. Antimicrobial activity. Planta Med 1979; 36(4):311-21.
• 27. Favel A, Steinmetz MD, Regli P, Vidal-Ollivier E, Elias R, Balansard G. In vitro antifungal activity of triterpenoid saponins. Planta Med 1994; 60(1):50-53.
• 28. Moulin-Traffort J, Favel A, Elias R, Regli P. Study of the action of alpha-hederin on the ultrastructure of Candida albicans. Mycoses 1998; 41(9-10):411-16.
• 29. Julien J, Gasquet M, Maillard C, Balansard G, Timon-David P. Extracts of the Ivy Plant, Hedera helix, and their Anthelminthic Activity on Liver Flukes. Planta Med 1985; 51(3):205-8.
• 30. Eguale T, Tilahun G, Debella A, Feleke A, Makonnen E. Haemonchus contortus: in vitro and in vivo anthelmintic activity of aqueous and hydro-alcoholic extracts of Hedera helix. Exp Parasitol 2007; 116(4):340-45.
• 31. Tedlaouti F, Gasquet M, Delmas F, Timon-David P, Elias R, Vidal-Ollivier E, Grespin F, Balansard G. Antitrypanosomial activity of some saponins from Calendula arvensis, Hedera helix and Sapindus mukurossi. Planta Med 1991; 57(2):A78.
• 32. Majester-Savornin B, Elias R, Diaz-Lanza AM, Balansard G, Gasquet M, Delmas F. Saponins of the ivy plant, Hedera helix, and their leishmanicidic activity. Planta Med 1991; 57(3):260-2.
• 33. Delmas F, Giorgio C Di, Elias R. Antileishmanial activity of three saponins isolated from ivy, α-hederin, β-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro. Planta Med 2000; 66(4):343-7.
• 34. Yakovishin LA, Ertahova VA, Bazyura EA. Influence of the triterpene glycosides and their complexes on mollusks. Ukrainica Bioorganica Acta 2006; 2:22-6.
• 35. Gülçin I, Mshvildadze V, Gepdiremen A, Elias R. Antioxidant activity of saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F. Planta Med 2004; 70(6):561-3.
• 36. Jeong HG, Park HJ: The prevention of carbon tetrachloride-induced hepatotoxicity in mice by hederin: Inhibition of cytochrome P450 2E1 expression IBUMB. Life 1998; 45:163-70.
• 37. Medeiros JMR, Macedo M, Contancia JP, Nguyen C, Cunningham G, Miles DH. Antithrombin activity of medicinal plants of the Azores. J Ethnopharmacol 2000; 72(1-2):157-65.
• 38. Quetin-Leclercq J, Elias R, Balansard G. Cytotoxic activity of some triterpenoid saponins. Planta Med 1992; 58(3):279-80.
• 39. Danloy S, Quetin-Leclercq J, Coucke P, De Pauw-Gillet MC, Elias R, Balansard G, Angenot L, Bassleer R. Effects of alpha-hederin, a saponin extracted from Hedera helix, on cells cultured in vitro. Planta Medica 1994; 60(1):45-9.
• 40. Elias R, De Méo M, Vidal-Ollivier E, Laget M, Balansard G, Dumenil G. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L. and Hedera helix L.. Mutagenesis 1990; 5(4):327-31.
• 41. Amara-Mokrane YA, Lehucher-Michel MP, Balansard G, Duménil G, Botta A. Protective effects of alfahederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagenesis 1996; 11:161-7.
• 42. Villani P, Orsière T, Sari-Minodier I, Bouvenot G, Botta A. In vitro study of the antimutagenic activity of alphahederin. Ann Biol Clin (Paris) 2001; 59(3):285-9.
• 43. Jors E: The prevalence of skin and mucosal symptoms in gardeners handling Ficus benjamina (weeping fig) and Hedera helix (ivy). A cross-sectional study. Ugeskr Laeger 2003; 8, 165(37):3526-9.
• 44. Duffy J, Baines D, Overmann GJ, Keen CL, Daston GP. Repeated administration of a-hederin results in alterations in matemal zinc status and adverse developmental outcome in the rat. Teratology 1997; 56(5):327-34.
• 45. Lanza JP, Steinmetz MD, Pellegrin E, Mourgue M. Actions toxique et pharmacodynamique sur le rat d’extraits de lierre grimpant (Hedera helix L.). Plantes Med Phytother 1980; 14:221-9.
• 46. Timon-David P, Julien J, Gasquet M, Balansard G, Bernard P. Recherche d’une activite antifongique de plusieurs principes actifs. Extraits du lierre grimpant: Hedera helix L. Ann Pharm Fr 1980; 38:545-52.
• 47. Gulyas A, Lämmlein MM. Zur Behandlung von Kindern mit chronisch-obstruktiver Bronchitis. Prospan- Kindersaft, ein altbewährtes Produkt in neuer Darreichungsformen – Ergebnisse einer klinischenPrüfung. Sozialpädiatrie 1992; 14:632-41.
• 48. Meyer-Wegener J, Liebscher K, Hettich M, Kastner HG. Efeu versus Ambroxol bei chronischer Bronchitis. Eine Doppelblindstudie zum Vergleich der klinischen Wirksamkeit und Verträglichkeit von Efeublätter trockenextrakt und Ambroxol. Z Allg Med 1993; 69:61-6.
• 49. Lässig W, Generlich H, Heydolph F, Paditz E. Wirksamkeit und Vertraglichkeit efeuhaltiger Hustenmittel. Prospan Kindersaft bei rezidivierenden obstructiven Atemwegserkrankungen. TW Padiätrie 1996; 9:489-91.
• 50. Gulyas A, Repges R, Dethlefsen U. Konsequente Therapie chronisch-obstruktiver Atemwegserkrankungen bei Kindern. Atemw-Lungenkrkh 1997; 23:291-4.
• 51. Hecker M. Efeublättertrockenextract: Hustentropfen mit Ethanol - deutlich bessere Wirksamkeit; Verschiedene Zubereitungen von Efeublättertrockenextract. Dosisanpassung erforderlich. T & E (Therapie & Erfolg) Pädiatrie 1997; 10:648-50.
• 52. Mansfeld HJ, Höhre H, Repges R, Dethlefsen U. Sekretolyse und Bronchospasmolyse. Klinische Studie:Behandlung von Kindern mit chronisch obstruktiven Atemwegserkrankungen mit Prospan. TW Padiatrie 1997;10:155-7.
• 53. Mansfeld HJ, Höhre H, Repges R, Dethlefsen U. Therapie des Asthma bronchiale mit Efeublätter- Trockenextrakt. Münch Med Wschr 1998;140:26-30.
• 54. Unkauf M, Friederich M. Bronchitis bei Kindern: klinische Studie mit Efeublätter Trockenextrakt. Der Bayerische Internist 2000;(4)suppl 2-4
• 55. Jahn E, Müller B. Efeublattertrockenextrakt. Pädiatrische Therapie-studie zur Wirksamkeit und Verträglichkeit. Dtsch Apoth Ztg 2000;140:1349-52.
• 56. Roth R. Anwendungsbeobachtung bestätigt Wirksamkeit der Behandlung mit Efeublätter Trockenextrakt. Efeublätter wirken sekretolytisch und bronchospasmolytisch. Pädiatrische Nachrichten. Dtsch Apoth Ztg 2000;140:1349-52,29.
• 57. Hecker M, Runkel F, Völp A. Behandlung chronischer Bronchitis mit einem Spezialextrakt aus Efeublättern – multizentrische Anwendungsbeobachtung mit 1350 Patienten. Forsch Komplementärmed Klass Naturheilkd 2002;9:77-84.
• 58. Büechi S, Vögelin R, Eiff MM, Ramos M, Melzer J. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch Komplementarmed Klass Naturheilkd 2005;12(6):312-313.
• 59. Kraft K. Tolerability of dried ivy leaf extract in children. Ztf Phytoth 2004;25:179-181.
• 60. Fazio S, Pouso J, Dolinsky D, Fernandez A, Hernandez M, Clavier G, Hecker M. Tolerance, safety andefficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine 2009;16(1):17-24.